Inhalation therapy is central to the treatment of patients with COPD, a condition that affects an estimated 480 million ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...

With cases of chronic obstructive pulmonary disease (COPD) rising in China, Lupin sees this partnership as a timely entry ...

Lupin and Sino Universal Pharmaceuticals partner to commercialize Tiotropium dry powder inhaler for COPD treatment in China.

With that, Theravance expects its lifetime value from the inhaler to come out to $1.52 billion. The drug stems from a 2002 ...